Accelerating assessment of therapies in hematology
What are the challenges of integrating therapy around autologous transplantation?
Lessons from the ASPIRE trial: three drug regimens as the new SOC for relapsed MM
Determining the progression of SMM using predictive biomarkers
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.